RHO and neoplasm: Moreover, since adhibin acts on cytokinesis and cell cycle progression by interfering with NM2-mediated and actin-based contractile ring closure through a deregulated Rho-mediated cell-cycle control122, it could hinder cancer cells from proliferating fast, thus delaying or even suppressing tumour dissemination.